Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. In addition, it has a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell CGM to medical facilities and individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd to research, develop, manufacture, and use CGM in the People's Republic of China, Hong Kong, Macau, and Taiwan. The company was founded in 1989 and is headquartered in Iselin, New Jersey.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ECTE
CUSIPN/A
Phone732-549-0128
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares12,000,000
Echo Therapeutics (OTCMKTS:ECTE) Frequently Asked Questions
What is Echo Therapeutics' stock symbol?
Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."
How were Echo Therapeutics' earnings last quarter?
Echo Therapeutics Inc (OTCMKTS:ECTE) announced its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) earnings per share (EPS) for the quarter. During the same quarter in the previous year, the firm earned ($0.97) EPS. View Echo Therapeutics' Earnings History.
Who are some of Echo Therapeutics' key competitors?
Some companies that are related to Echo Therapeutics include Medtronic (MDT), SONOVA Hldg AG/ADR (SONVY), Varian Medical Systems (VAR), Masimo (MASI), LivaNova (LIVN), GETINGE AB/ADR (GNGBY), CONMED (CNMD), NxStage Medical (NXTM), AxoGen (AXGN), Natus Medical (BABY), Cutera (CUTR), Viewray (VRAY), Rockwell Medical (RMTI), Vision Sciences (CGNT) and Helius Medical Technologies (HSDT).
Who are Echo Therapeutics' key executives?
Echo Therapeutics' management team includes the folowing people:
- Mr. Alan W. Schoenbart CPA, Chief Exec. Officer, Chief Financial Officer and Director (Age 59)
- Ms. Christine H. Olimpio, Director of Investor Relations & Corp. Communications
Has Echo Therapeutics been receiving favorable news coverage?
Headlines about ECTE stock have been trending somewhat positive on Saturday, according to Accern Sentiment. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Echo Therapeutics earned a coverage optimism score of 0.07 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 45.49 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Echo Therapeutics?
Shares of ECTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Echo Therapeutics' stock price today?
One share of ECTE stock can currently be purchased for approximately $0.0070.
How big of a company is Echo Therapeutics?
Echo Therapeutics has a market capitalization of $90,000.00.
How can I contact Echo Therapeutics?
Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The medical device company can be reached via phone at 732-549-0128 or via email at [email protected]
MarketBeat Community Rating for Echo Therapeutics (ECTE)
MarketBeat's community ratings are surveys of what our community members think about Echo Therapeutics and other stocks. Vote "Outperform" if you believe ECTE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ECTE will underperform the S&P 500 over the long term. You may vote once every thirty days.
